What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Enzyme
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Neuropeptide Y receptor, Vasoconstriction and Endothelin receptor.
His Internal medicine study which covers Cardiology that intersects with Inflammation.
He combines subjects such as Catecholamine, Circulatory system and Stimulation, Guanethidine with his study of Neuropeptide Y receptor.
His Vasoconstriction research is multidisciplinary, relying on both Vas deferens, Spleen, Kidney and Forearm.
He has researched Endothelin receptor in several fields, including Brachial artery and Endothelin 1.
His studies deal with areas such as Pharmacology and Arginase as well as Nitric oxide.
His most cited work include:
- The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. (348 citations)
- Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. (190 citations)
- Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation (183 citations)
What are the main themes of his work throughout his whole career to date?
John Pernow mainly investigates Internal medicine, Endocrinology, Cardiology, Ischemia and Nitric oxide.
Internal medicine and Arginase are frequently intertwined in his study.
Endocrinology connects with themes related to Neuropeptide Y receptor in his study.
His work on Myocardial infarction, Coronary artery disease, Infarct size and St elevation myocardial infarction as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines.
His Ischemia research integrates issues from Anesthesia and Pharmacology.
His Endothelin receptor research incorporates elements of Blockade and Vasodilation.
He most often published in these fields:
- Internal medicine (79.02%)
- Endocrinology (53.50%)
- Cardiology (27.62%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (79.02%)
- Endothelial dysfunction (21.33%)
- Pharmacology (16.08%)
In recent papers he was focusing on the following fields of study:
John Pernow mainly focuses on Internal medicine, Endothelial dysfunction, Pharmacology, Ischemia and Arginase.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Cardiology.
His research in Endocrinology intersects with topics in Cardiomyopathy and Function.
His biological study spans a wide range of topics, including Diabetes mellitus, Nitric oxide and Soluble guanylyl cyclase.
His work on Reperfusion injury as part of his general Ischemia study is frequently connected to Sinus rhythm, thereby bridging the divide between different branches of science.
He has researched Arginase in several fields, including Type 2 diabetes and Endothelin 1.
Between 2017 and 2021, his most popular works were:
- Circulating blood cells and extracellular vesicles in acute cardioprotection (49 citations)
- Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I (47 citations)
- Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery disease (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Diabetes mellitus
His primary areas of investigation include Endothelial dysfunction, Arginase, Nitric oxide, Ischemia and Type 2 diabetes.
His Endothelial dysfunction study integrates concerns from other disciplines, such as Immunology, Enos, Receptor, Signal transduction and Intracellular.
His Arginase research is multidisciplinary, relying on both Internal medicine, Endothelin 1 and Endocrinology.
John Pernow does research in Internal medicine, focusing on Cardiac function curve specifically.
His Nitric oxide research is multidisciplinary, incorporating perspectives in Hemoglobin, Plethysmograph, Red blood cell, Reactive oxygen species and Nitrosation.
The concepts of his Ischemia study are interwoven with issues in Diabetes mellitus, Hemostatic function and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
